Forte BioSciences Inc(FBRX)

盘后76.500.000.00%17:05 EDT

76.50+21.72+39.65%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Forte BioSciences盘前爆升39%，Argenx将以每股77美元现金收购Forte Biosciences
  老虎资讯综合 · 07-27 17:34
  Forte BioSciences盘前爆升39%，Argenx将以每股77美元现金收购Forte Biosciences
- Forte Biosciences美股盘前大涨近39%
  第一财经 · 07-27 17:27
  Forte Biosciences美股盘前大涨近39%
- Argenx(ARGX.US)豪掷22亿美元、溢价40%收购Forte Biosciences(FBRX.US) 加码布局免疫学药物组合
  智通财经 · 07-27 14:52
  Argenx(ARGX.US)豪掷22亿美元、溢价40%收购Forte Biosciences(FBRX.US) 加码布局免疫学药物组合
- Argenx豪掷22亿美元、溢价40%收购Forte Biosciences
  老虎资讯综合 · 07-27 13:08
  Argenx豪掷22亿美元、溢价40%收购Forte Biosciences
- FB102展现强劲安全性，不良反应仅轻至中度
  美股速递 · 07-09
  FB102展现强劲安全性，不良反应仅轻至中度
- Forte Biosciences, Inc.盘中异动股价大涨7.18%
  市场透视 · 03-03
  Forte Biosciences, Inc.盘中异动股价大涨7.18%
- Forte Biosciences, Inc.股价拉升10.45% 市值涨1799.58万美元
  市场透视 · 02-06
  Forte Biosciences, Inc.股价拉升10.45% 市值涨1799.58万美元
- Forte Biosciences, Inc.盘中异动股价大跌8.92%报5.92美元
  市场透视 · 2025-03-10
  Forte Biosciences, Inc.盘中异动股价大跌8.92%报5.92美元
- Forte Biosciences, Inc.盘中异动临近收盘快速下跌5.60%报7.25美元
  市场透视 · 2025-03-05
  Forte Biosciences, Inc.盘中异动临近收盘快速下跌5.60%报7.25美元
- Forte Biosciences, Inc.盘中异动大幅下挫5.49%报8.60美元
  市场透视 · 2025-03-04
  Forte Biosciences, Inc.盘中异动大幅下挫5.49%报8.60美元
- Forte Biosciences, Inc.盘中异动快速上涨5.27%报9.79美元
  市场透视 · 2025-02-28
  Forte Biosciences, Inc.盘中异动快速上涨5.27%报9.79美元
- Forte Biosciences, Inc.盘中异动快速拉升9.10%报10.23美元
  市场透视 · 2025-02-27
  Forte Biosciences, Inc.盘中异动快速拉升9.10%报10.23美元
- Forte Biosciences, Inc.盘中异动早盘急速下挫5.08%报9.16美元
  市场透视 · 2025-02-26
  Forte Biosciences, Inc.盘中异动早盘急速下挫5.08%报9.16美元
- Forte Biosciences, Inc.盘中异动临近收盘大幅跳水5.69%报10.36美元
  市场透视 · 2025-02-25
  Forte Biosciences, Inc.盘中异动临近收盘大幅跳水5.69%报10.36美元
- Forte Biosciences, Inc.盘中异动快速拉升5.00%
  市场透视 · 2025-02-19
  Forte Biosciences, Inc.盘中异动快速拉升5.00%
- Forte Biosciences, Inc.盘中异动股价大涨6.36%报11.70美元
  市场透视 · 2025-02-14
  Forte Biosciences, Inc.盘中异动股价大涨6.36%报11.70美元
- Forte Biosciences, Inc.盘中异动临近收盘股价大涨8.12%报11.92美元
  市场透视 · 2025-02-12
  Forte Biosciences, Inc.盘中异动临近收盘股价大涨8.12%报11.92美元
- Forte Biosciences, Inc.盘中异动股价大跌6.38%
  市场透视 · 2025-02-11
  Forte Biosciences, Inc.盘中异动股价大跌6.38%
- Forte Biosciences, Inc.盘中异动大幅上涨5.77%报13.75美元
  市场透视 · 2025-02-07
  Forte Biosciences, Inc.盘中异动大幅上涨5.77%报13.75美元
- Forte Biosciences, Inc.盘中异动股价大涨5.80%
  市场透视 · 2025-02-06
  Forte Biosciences, Inc.盘中异动股价大涨5.80%
公司概况
公司名称
Forte BioSciences Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.fortebiorx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Forte Biosciences, Inc.是一家临床阶段的皮肤病学公司，致力于开发用于治疗炎症性皮肤病的活体生物疗法FB-401。 FB-401已完成对成人和儿童（3岁及以上）特应性皮炎患者的1/2a期测试。对于安全和有效的疗法，特别是对于小儿特应性皮炎患者，存在大量的需求。Forte计划在2020年代中期将FB-401推进到2期临床试验中。
- 07-16
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 07-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 07-08
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 06-08
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 06-02
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 06-02
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-15
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-14
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 05-14
  超过5%披露
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 05-13
  超过5%披露
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
  Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
- 05-11
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]

分时
5日
日
周
月

数据加载中...

最高

76.60

今开

76.41

量比

25.89

最低

76.38

昨收

54.78

换手率

89.01%

Forte BioSciences Inc(FBRX)

公司概况

热议股票